Fox Business - The Power to Prosper
Search Site

Bayer AG

Outlook for biotech

Piper Jaffray senior analyst Ted Tenthoff gives tips for investing in the biotech sector.

Read More

  1. Veeva Systems Files for $150M IPO

    Life sciences-focused software company Veeva Systems Inc filed with U.S. regulators to raise up to $150 million in an initial public offering of its common stock.Vee...

  2. Is Amgen’s Acquisition of Onyx a Good Move?

    S&P Capital IQ biotech equity analyst Steve Silver on Amgen’s deal to buy Onyx.

  3. Amgen Snags Onyx in $10.4 Billion Deal

    Amgen (NASDAQ:AMGN) agreed to buy Onyx Pharmaceuticals (NASDAQ:ONXX) late Sunday for $10.4 billion in a deal that will combine two of the biggest makers of cancer dr...

  4. Amgen seeks to bolster drug pipeline with $10.4 billion Onyx buy

    Amgen Inc struck a deal to buy cancer drug maker Onyx Pharmaceuticals Inc for about $10.4 billion on Sunday, as it moves to restock its product pipeline in response ...

  5. Amgen to buy Onyx for more than $10 billion

    Amgen Inc struck a deal to buy Onyx Pharmaceuticals Inc for more than $10 billion on Sunday, ending a two- month-long auction for the cancer drug maker.Amgen said it...

  6. Amgen close to buying Onyx for $125 per share: sources

    Amgen Inc is close to buying Onyx Pharmaceuticals Inc for $125 per share, or more than $10 billion, in a deal that is expected to be announced as soon as Monday, two...

  7. Amgen close to buying Onyx for $125 per share

    Amgen Inc is close to buying Onyx Pharmaceuticals Inc for $125 per share, or more than $10 billion, in a deal that is expected to be announced as soon as Monday, two...

  8. Market Wrap For Monday, August 5: Stocks Close Mixed; Nasdaq Rises, Dow And S&P Fall Modestly

    It was an extremely quiet trading session to start the week on Monday despite the Dow and S&P 500 sitting near new all-time highs .Volume was anemic on a slow news d...

  9. Compugen Shares Up After R&D Agreement With Bayer

    Shares of Compugen Ltd. [s:cgen] jumped 58% in premarket trade after the company said it had signed an agreement with Bayer AG for the research, development and comm...

  10. Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)

    Things are starting to heat up in the already hot pharmaceutical sector especially as it relates to mergers and acquisitions.Only days after Onyx Pharmaceuticals (NA...

  11. Pfizer, Novartis may join Amgen in bidding for Onyx: sources

    Onyx Pharmaceuticals Inc , whose cancer drugs promise a strong revenue stream, is attracting preliminary buyout interest from several large pharmaceutical companies ...

  12. ETFs For an Onyx Takeover Battle

    Mergers and acquisitions activity in the biotechnology sector may have been in a slumber for much of 2013, but that changed last Friday when Onyx Pharmaceuticals (NA...

  1. Biotechs Still Hold Promise in 2014 and Beyond

    As a group, biotech companies were among the best performers in what was a stellar year for U.S. stocks: The group was up 66%, outpacing the broader market by a stag...

  2. Europe Stocks Open Higher After Holiday Break

    European stock markets resumed trading on Friday on an up note, tracking gains seen in Wall Street the prior session. Markets were closed both Wednesday and Thursday...

  3. Europe Stocks Cautiously Up, Led By Oil Majors

    European stock markets opened slightly higher on Friday as investors readied for U.S. nonfarm payrolls due for release later. The Stoxx Europe 600 index rose 0.3% to...

  4. Report: Novartis Opens Animal Health Books to Bayer , Lilly

    Swiss drugmaker Novartis is ready to sell its animal health subsidiary and has opened its books to Bayer and other rivals interested in a business that could change ...

  5. Merck Invests $107M in China Drug Plant

    German drugmaker Merck KGaA has invested 80 million euros ($107.67 million) in a manufacturing plant in China, the company said on Friday, underlining the importance...

  6. Europe Stocks Up; Ryanair, Weir Sink On Warnings

    European stock markets opened higher on Monday, with heavyweight banks, chemical stocks and pharmaceuticals leading the gains. The Stoxx Europe 600 index rose 0.5% t...

  7. German Stocks at a New Historic High (EWG, EWGS, DBGR)

    Investor confidence increased in Germany and the countrys stock market rallied to a new all-time high last night.The German ZEW survey of investor confidence came in...

‹ Prev12345Next ›
Freebase CC-BY
Source: Bayer AG on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL